Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Turn Therapeutics Inc.
Turn Therapeutics Reports Interim Analysis Findings and Adaptive Optimization Strategy from Phase 2 GX-03 Trial in Moderate-to-Severe Atopic Dermatitis
June 01, 2026
From
Turn Therapeutics Inc.
Via
Business Wire
Tickers
TTRX
Turn Therapeutics Announces Peer-Reviewed Publication in Journal of Dermatological Treatment Highlighting GX-03 Activity in IL-36 Associated Inflammatory Model
May 27, 2026
From
Turn Therapeutics Inc.
Via
Business Wire
Tickers
TTRX
Turn Therapeutics to Present at Jefferies Global Healthcare Conference 2026
May 19, 2026
From
Turn Therapeutics Inc.
Via
Business Wire
Tickers
TTRX
Turn Therapeutics Appoints Physician-Scientist and Former FDA Commissioner, Dr. Stephen M. Hahn, as Executive Clinical and Regulatory Lead
May 18, 2026
From
Turn Therapeutics Inc.
Via
Business Wire
Tickers
TTRX
Turn Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updates
May 11, 2026
From
Turn Therapeutics Inc.
Via
Business Wire
Tickers
TTRX
Turn Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates
March 31, 2026
From
Turn Therapeutics Inc.
Via
Business Wire
Tickers
TTRX
Turn Therapeutics to Present at Upcoming TD Cowen and Oppenheimer Healthcare Conferences
February 09, 2026
From
Turn Therapeutics Inc.
Via
Business Wire
Tickers
TTRX
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.